Design of oral insulin delivery systems

Journal of Drug Targeting

Volumn 18, Issue 2, 2010, Pages 79-92

  Wong, Tin Wui ^a  

^a UNIVERSITI TEKNOLOGI MARA   (Malaysia)

Author keywords

Diabetes; Insulin; Oral

Indexed keywords

CLATHRIN; GLUCOSE; INSULIN; NANOPARTICLE; RECOMBINANT HUMAN INSULIN; TRANSFERRIN;

CHEMICAL MODIFICATION; COUGHING; DIABETIC PATIENT; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG FORMULATION; DRUG RELEASE; DRUG RETENTION; DRUG STABILITY; DRUG TARGETING; ENCAPSULATION; HUMAN; HYDROGEL; HYPOGLYCEMIA; INJECTION SITE INFECTION; INSULIN DEPENDENT DIABETES MELLITUS; INTESTINE ABSORPTION; LIPOATROPHY; LIPOHYPERTROPHY; MICROPARTICLE ENZYME IMMUNOASSAY; MUCOADHESION; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REVIEW; SINGLE DRUG DOSE;

DIABETES MELLITUS; DRUG ADMINISTRATION ROUTES; DRUG DELIVERY SYSTEMS; HUMANS; INSULIN;

EID: 75149194285     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/10611860903302815     Document Type: Review

References (87)

1. Adams G, Wang N, Cui Y. (2005). Future alternative therapies in a quest to halt aberrations in diabetes mellitus. Biomed Pharmacother, 59: 296-301
2. Anita L, Santani DD. (2007). Pulsatile drug delivery systems. Ind J Pharm Sci, 69(4): 489-497
3. Aoki Y, Morishita M, Takayama K. (2005a). Role of mucous/glycocalyx layers in insulin permeation across the rat ileal membrane. Int J Pharm, 297: 98-109
4. Aoki Y, Morishita M, Asai K, Akikusa B, Hosoda S, Takayama K. (2005b). Region-dependent role of the mucous/glycocalyx layers in insulin permeation across rat small intestinal membrane. Pharm Res, 22(11): 1854-1862 (Pubitemid 41504338)
5. Arnolds S, Heise T. (2007). Inhaled insulin. Best Pract Clin Endocrinol Metab, 21(4): 555-571
6. Bai JPF, Chang LL. (1996). Effects of enzyme inhibitors and insulin concentration on transepithelial transport of insulin in rats. J Pharm Pharmacol, 48: 1078-1082
7. Baker JC, Hanquier JM. (1997). Acylated insulin analogs. US Patent 5693609
8. Banerjee D, Flanagan PR, Cluett J, Valberg LS. (1986). Transferrin receptors in the human gastrointestinal tract. Relationships to body iron stores. Gastroenterology, 91: 861-869
9. Belchetz P, Hammond P. (2004). Mosby's Color Atlas and Text of Diabetes and Endocrinology. Spain: Elsevier Ltd
10. Bernkop-Schnürch A. (1998). The use of inhibitory agents to overcome the enzymatic barrier to perorally administered therapeutic peptides and proteins. J Control Release, 52: 1-16
11. British Pharmacopoeia (1998). Human Insulin (pp. 725-727), Vol.I. London: The Stationery Office Ltd
12. Calceti P, Salmaso S, Walker G, Bernkop-Schnürch A. (2004). Development and in vivo evaluation of an oral insulin-PEG delivery system. Eur J Pharm Sci, 22: 315-323
13. Cano-Cebrián M.J, Zornoza T, Granero L, Polache A. (2005). Intestinal absorption enhancement via the paracellular route by fatty acids, chitosans and others: A target for drug delivery. Curr Drug Deliv, 2: 9-22
14. Carino GP, Mathiowitz E. (1999). Oral insulin delivery. Adv Drug Deliv Rev, 35: 249-257
15. Chan KK, Mei H. (2000). Lipid-modified insulin incorporated liposomes for selectively delivering cytotoxic agents to hepatoma cells. US Patent 6159931
16. Cheng K, Lim L-Y. (2004). Insulin-loaded calcium pectinate nanoparticles: Effects of pectin molecular weight and formulation pH. Drug Dev Ind Pharm, 30(4): 359-367
17. Chu JS. (2003). Advances in colon-specific drug delivery systems employing the CODES™. The Drug Delivery Companies Report Autumn/Winter 36-40
18. Cui F, Shi K, Zhang L, Tao A, Kawashima Y. (2006). Biodegradable nanoparticles loaded with insulin-phospholipid complex for oral delivery: Preparation, in vitro characterization and in vivo evaluation. J. Control Release, 114: 242-250
19. Damgé C, Maincent P, Ubrich N. (2007). Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats. J. Control Release, 117: 163-170
20. Delie F. (1998). Evaluation of nano-and microparticle uptake by the gastrointestinal tract. Adv. Drug Deliv. Rev. 34: 221-233
21. Ertl B, Heigl F, Wirth M, Gabor F. (2000). Lectin-mdiated bioadhesion: preparation, stability and Caco-2 binding of wheat germ agglutinin- functionalized poly(D, L-lactic-co-glycolic acid)-microspheres. J Drug Target, 8(3): 173-184
22. Fasano A. (1998). Innovative strategies for the oral delivery of drugs and peptides. Trends Biotechnol, 16(4): 152-157
23. Flood T. (2006). Advances in insulin delivery systems and devices: Beyond the vial and syringe. Insulin, 1(3): 99-108
24. Foss A.C, Goto T, Morishita M, Peppas NA. (2004). Development of acrylic-based copolymers for oral insulin delivery. Eur J Pharm Biopharm, 57: 163-169
25. Gabor F, Schwarzbauer A, Wirth M. (2002). Lectin-mediated drug delivery: Binding and uptake of BSA-WGA conjugates using the Caco-2 model. Int J Pharm, 237: 227-239
26. Grabovac V, Föger F, Bernkop-Schnürch A. (2008). Design and in vivo evaluation of a patch delivery system for insulin based on thiolated polymers. Int J Pharm 348: 169-174
27. Graves PM, Eisenbarth GS. (1999). Pathogenesis, prediction and trials for the prevention of insulin-dependent (type 1) diabetes mellitus. Adv Drug Del Rev, 35: 143-156
28. Hinds KD, Kim SW. (2002). Effects of PEG conjugation on insulin properties. Adv Drug Deliv Rev, 54(4): 505-530
29. Hinds KD, Campbell KM, Holland KM, Lewis DH, Piché CA, Schmidt PG. (2005). PEGylated insulin in PLGA microparticles. In vivo and in vitro analysis. J Control Release, 104: 447-460
30. Hite P.F, Barnes AM, Johnston PE. (2006). Exhuberance over Exubera. Clin Diabet, 24(3): 110-114
31. Hollander P.A. (2007). Evolution of a pulmonary insulin delivery system (Exubera) for patients with diabetes. Medscape General Med, 9(1): 45
32. Hosny EA, Al-Shora HI, Elmazar MMA. (2002). Oral delivery of insulin from enteric-coated capsules containing sodium salicylate: effect on relative hypoglycemia of diabetic beagle dogs. Int J Pharm 237: 71-76
33. Hou Z, Zhang Z, Zhang C, Huang M. (2004). Use of natural plant exudates (Sanguis Draxonis) for sustained oral insulin delivery with dramatic reduction of glycemic effects in diabetic rats. J. Controll Release, 97: 467-475
34. Hovgaard Lars, Jacobs H, Wilson DE, Kim SW. (1996). Stabilization of insulin by alkylmaltosides. B. Oral absorption in vivo in rats. Int J Pharm, 132: 115-121
35. Irache JM, Durrer C, Duchêne D, Ponchel G. (1994). In vitro study of lectin-latex conjugates for specific bioadhesion. J Control Release, 31: 181-188
36. Jain S, Hreczuk-Hirst D.H, McCormack B, Mital M, Epenetos A, Laing P, Gregoriadis G. (2003). Polysialylated insulin: synthesis, characterization and biological activity in vivo. Biochim Biophys Acta, 1622: 42-49
37. Jasti BR, Marasanapalle V, Li X. (2002). Barriers to the delivery of proteins and peptides. American Pharmaceutical Review
38. Jeandidier N, Boivin S. (1999). Current status and future prospects of parenteral insulin regimens, strategies and delivery systems for diabetes treatment. Adv Drug Deliv Rev, 35: 179-198
39. Kajii T, Hori T, Hayashi M, Awazu S. (1986). Effect of salicylic acid on the permeability of plasma membrane of the small intestine of the rat: fluorescence spectroscopic approach to elucidate the mechanism of promoted drug absorption. J Pharm Sci, 75(5): 475-478
40. Katsuma M, Watanabe S, Kawai H, Takemura S, Sako K. (2006). Effects of absorption promoters on insulin absorption through colontargeted delivery. Int J Pharm, 307: 156-162
41. Kim JJ, Park K. (2001). Modulated insulin delivery from glucose-sensitive hydrogel dosage forms. J Control Release, 77: 39-47
42. Kim B-Y, Jeong JH, Park K, Kim J-D. (2005). Bioadhesive interaction and hypoglycemic effect of insulin loaded lectin-microparticle conjugates in oral insulin delivery system. J Control Release, 102: 525-538
43. King H, Aubert RE, Herman WH. (1998). Global burden of diabetes, 1995-2025. Diabetes Care, 21(9): 1414-1431
44. Krauland AH, Guggi D, Bernkop-Schnürch A. (2004). Oral insulin delivery: the potential of thiolated chitosan-insulin tablets on non-diabetic rats. J Control Release, 95: 547-555
45. Lacombe O, Woodley J, Solleux C, Delbos J-M, Boursier-Neyret C, Houin G. (2004). Localization of drug permeability along the rat small intestine, using markers of the paracellular, transcellular and some transporter routes. Eur J Pharm Sci, 23: 385-391
46. Lehr C-M. (2000). Lectin-mediated drug delivery: the second generation of bioadhesives. J Control Release, 65: 19-29
47. Li J, Yang L, Ferguson S.M, Hudson TJ, Watanabe S, Katsuma M, Fix JA. (2002). In vitro evaluation of dissolution behaviour for a colon-specific drug delivery system (CODES™) in multi-pH media using United States Pharmacopeia apparatus II and III. AAPS Pharm Sci Tech 3(4): article 33
48. Li M-G, Lu W-L, Wang J-C, Zhang X, Wang X-Q, Zheng A-P, Zhang Q. (2007). Distribution, transition, adhesion and release of insulin loaded nanoparticles in the gut of rats. Int J Pharm, 329: 182-191
49. Lim C-J, Shen W-C. (2005). Comparison of monomeric and oligomeric transferrin as potential carrier in oral delivery of protein drugs. J Control Release, 106: 273-286
50. Lin Y-H, Chen C-T, Liang H-F, Kulkarni AR, Lee P-W, Chen C-H, Sung H-W. (2007). Novel nanoparticles for oral insulin delivery via the paracellular pathway. Nanotechnol. 18: doi: 10.1088/0957-4484/18/10/105102 (Pubitemid 46472243)
51. Lubben IMVD, Konings FAJ, Borchard G, Verhoef JC, Junginger HE. (2001). In vivo uptake of chitosan microparticles by murine peyer's patches: visualization studies using confocal laser scanning microscopy and immunohistochemistry. J Drug Target, 9(1): 39-47
52. Ma Z, Lim L-Y. (2003). Uptake of chitosan and associated insulin in Caco-2 cell monolayers: A comparison between chitosan molecules and chitosan nanoparticles. Pharm Res 20(11): 1812-1819
53. Ma Z, Lim TM, Lim L-Y. (2005). Pharmacological activity of peroral chitosan-insulin nanoparticles in diabetic rats. Int J Pharm 293: 271-280
54. Mandal TK. (2005). Inhaled insulin for diabetes mellitus. Am J Health-Syst Pharm 62(13): 1359-1364
55. Mastrandrea LD, Quattrin T. (2006). Clinical evaluation of inhaled insulin. Adv Drug Deliv Rev, 58: 1061-1075
56. Morishita M, Goto T, Peppas NA, Joseph JI, Torjman M.C, Munsick C, Nakamura K, Yamagata T, Takayama K, Lowman AM. (2004). Mucosal insulin delivery systems based on complexation polymer hydrogels: effect of particle size on insulin enteral absorption. J Control Release, 97: 115-124
57. Morishita M, Goto T, Nakamura K, Lowman AM, Takayama K, Peppas NA. (2006). Novel oral insulin delivery systems based on complexation polymer hydrogels: single and multiple administration studies in type 1 and 2 diabetic rats. J Control Release, 110: 587-594
58. Moslemi P, Najafabadi AR, Tajerzadeh H. (2003). A rapid and sensitive method for simultaneous determination of insulin and A21-desamido insulin by high performance liquid chromatography. J Pharm Biomed Anal, 33: 45-51
59. Muranushi N, Mack E, Kim SW. (1993). The effects of fatty acids and their derivatives on the intestinal absorption of insulin in rat. Drug Dev Ind Pharm, 19(8): 929-941
60. Musabayane CT, Munjeri O, Bwititi P, Osim EE. (2000). Orally administered, insulin-loaded amidated pectin hydrogel beads sustain plasma concentrations of insulin in streptozotocin-diabetic rats. J Endocrinol, 164: 1-6
61. Nakamura K, Murray RJ, Joseph JI, Peppas NA, Morishita M, Lowman AM. (2004). Oral insulin delivery using P(MAA-g-EG) hydrogels: effects of network morphology on insulin delivery characteristics. J Control Release, 95: 589-599
62. Pan Y, Li Y-J, Zhao H-Y, Zheng J-M, Xu H, Wei, G, Hao J-S, Cui F-D. (2002). Bioadhesive polysaccharide in protein delivery system: chitoan nanoparticles improve the intestinal absorption of insulin in vivo. Int J Pharm, 249: 139-147
63. Patton JS, Bukar J, Nagarajan S. (1999) Inhaled insulin. Adv Drug Deliv Rev, 35: 235-247
64. Peppas NA, Kavimandan NJ. (2006). Nanoscale analysis of protein and peptide absorption: Insulin absorption using complexation and pH-sensitive hydrogels as delivery vehicles. Eur J Pharm Sci, 29(3-4): 183-197
65. Pillai, O, Panchagnula R. (2001). Insulin therapies-past, present and future. Drug Discov. Today, 6(20): 1056-1061
66. Ramkissoon-Ganorkar C, Liu F, Baudyš M, Kim SW. (1999). Modulating insulin-release profile from pH/thermosensitive polymeric beads through polymer molecular weight. J Control Release, 59: 287-298
67. Rosa G.D, Iommelli R, Rotonda M.I.L, Miro A, Quaglia F. (2000). Influence of the co-encapsulation of different non-ionic surfactants on the properties of PLGA insulin-loaded microspheres. J Control Release, 69: 283-295
68. Saffran M, Pansky B, Budd GC, Williams FE. (1997). Insulin and gastrointestinal tract. J Control Release, 46: 89-98.
69. Sajeesh S, Sharma CP. 2006 Cyclodextrin-insulin complex encapsulated polymethacrylic acid based nanoparticles for oral insulin delivery. Int J Pharm, 325: 147-154 (Pubitemid 44573692)
70. Sarmento B, Ribeiro A, Veiga F, Ferreira D. (2006). Development and characterization of new insulin containing polysaccharide nanoparticles. Coll. Surf B: Biointerf, 53(2): 193-202
71. Schultz SG. (1977). Some properties and consequences of low resistance paracellular pathways across the small intestine: The advantages of being "leaky". In M. Kramer and F. Lauterbach (eds.), Intestin Permeat Ex Med, 391: 382-392
72. Shah D, Shen WC. (1996). Transcellular delivery of an insulin-transferrin conjugate in enterocyte-like Caco-2 cells. J Pharm Sci, 85(12): 1306-1311
73. Shao Z, Li Y, Krishnamoorthy R, Chermak T, Mitra AK. (1993). Differential effects of anionic, cationic, nonionic, and physiologic surfactants on the dissociation, α-chymotryptic degradation, and enteral absorption of insulin hexamers. Pharm Res, 10(2): 243-251
74. Suzuka T, Tata N, Sakai K, Nishihata T. (1988). The effect of salicylate concentration on the uptake of salicylate and cefmetazole into rat isolated small intestine epithelial cells. J Pharm Pharmacol, 40(7): 469-472 (Pubitemid 18177197)
75. Szabo S, Trier JS, Frankel PW. (1981). Sulfhydryl compounds may mediate gastric cytoprotection. Science, 214: 200-202
76. Takei I, Kasatani T. (2004). Future therapy of diabetes mellitus. Biomed Pharmacother, 58: 578-581
77. Tao SL, Desai TA. (2005) Gastrointestinal patch systems for oral drug delivery. Drug Discovery Today, 10(13): 909-915
78. Teply BA, Tong R, Jeong S.Y, Luther G, Sherifi I, Yim C.H, Khademhosseini A, Farokhzad OC, Langer RS, Cheng J. (2008). The use of charged-coupled polymeric microparticles and micromagnets for modulating the bioavailability of orally delivered macromolecules. Biomaterials, 29: 1216-1223
79. Wan J, Taub ME, Shah D, Shen WC. (1992) Brefeldin A enhances receptor-mediated transcytosis of transferrin in filter-grown Madin-Darby canin kidney cells. J Biol Chem, 267(19): 13446-13450
80. Wikipedia (2008) Inhalable insulin
81. Whitehead K, Shen Z, Mitragotri S. (2004). Oral delivery of macromolecules using intestinal patches: application for insulin delivery. J. Control Release, 98: 37-45
82. WHO. (1999). Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. World Health Organization, Department of Noncommunicable Disease Surveillance, Geneva
83. Wong TW. (2009). Chitosan and its use in design of insulin delivery system. Recent Pat Drug Deliv Formulation, 3: 8-25
84. Xia CQ, Shen W-C. (2001) Tyrphostin-8 enhances transferrin receptor-mediated transcytosis in Caco-2 cells and increases hypoglycemic effect of orally administered insulin-transferrin conjugate in diabetic rats. Pharm Res, 18(2): 191-195.
85. Yamagata T, Morishita M, Kavimandan N.J, Nakamura K, Fukuoka Y, Takayama K, Peppas N.A. 2006 Characterization of insulin protection properties of complexation hydrogels in gastric and intestinal enzyme fluids. J Control Release, 112: 343-349
86. Yin L, Fei L, Cui F, Tang C, Yin C. (2007). Superporous hydrogels containing poly(acrylic acid-co-acrylamide)/O-carboxymethyl chitosan interpenetrating polymer networks. Biomaterials, 28: 1258-1266
87. Yin L, Ding JY, Fei L, He M, Cui F, Tang C, Yin C. (2008). Beneficial properties for insulin absorption using superporous hydrogel containing interpenetrating polymer network as oral delivery vehicles. Int J Pharm, 350: 220-229